Cargando…
Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA(+) individuals without a systemic autoimmune rheumatic disease diagnosis
BACKGROUND: Elevated levels of interferons (IFNs) are a characteristic feature of systemic autoimmune rheumatic diseases (SARDs) and may be useful in predicting impending symptomatic progression in anti-nuclear antibody-positive (ANA(+)) individuals lacking a SARD diagnosis. Typically, these are mea...
Autores principales: | Kim, Sonya T., Muñoz-Grajales, Carolina, Dunn, Shannon E., Schneider, Raphael, Johnson, Sindhu R., Touma, Zahi, Ahmad, Zareen, Bonilla, Dennisse, Atenafu, Eshetu G., Hiraki, Linda T., Bookman, Arthur, Wither, Joan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912609/ https://www.ncbi.nlm.nih.gov/pubmed/36765391 http://dx.doi.org/10.1186/s13075-023-02997-w |
Ejemplares similares
-
Presence of an interferon signature in individuals who are anti-nuclear antibody positive lacking a systemic autoimmune rheumatic disease diagnosis
por: Wither, Joan, et al.
Publicado: (2017) -
Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies
por: Gupta, Rashi, et al.
Publicado: (2022) -
Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis
por: Whittall-Garcia, Laura, et al.
Publicado: (2022) -
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease
por: Baglaenko, Yuriy, et al.
Publicado: (2018) -
The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus
por: Mai, Lloyd, et al.
Publicado: (2021)